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Objectives. Our aim was to study the clinical characteristics 
and evolution of symptoms and left ventricular function in a 
clinically homogeneous group of patients with syndrome X (angi- 
na pectoris, positive exercise test results and normal coronary 
arteriograms). 
Background. The syndrome of angina with normal coronary 
arteriograms i heterogeneous and encompasses different patho- 
genetic entities. These characteristics may contribute to the 
existing controversy concerning the cause of syndrome X. 
Methods. We studied 99 patients with syndrome X (78 women, 
21 men; mean age -+ SD 48.5 _+ 8 years). All underwent clinical 
characterization, ambulatory electrocardiographic (ECG) moni- 
toring and echocardiographic assessment ofleft ventricular func- 
tion during a follow-up eriod of 7 -+ 4 years. 
Results. The syndrome was more common in women than in 
men. Of the women, 61.5% were postmenopausal before the onset 
of chest pain. All 99 patients had exertional angina, and 41 also 
had rest angina. The average duration of episodes of chest pain 
was > 10 rain in 53% of patients. Sublingual nitrate was effective 
for relief of pain in 42% of patients. Transient ST segment 
depression was observed uring ambulatory ECG monitoring in 
64 patients and myocardial perfusion abnormalities in22. During 
the first stage of the exercise test, 32 patients had an increase 
>20 mm Hg in systolic blood pressure and showed an earlier 
onset of ST depression and shorter exercise time than did patients 
whose blood pressure increased _<20%. During follow-up, no 
deaths or myocardial infarctions occurred, ventricular function 
was unchanged (shortening fraction 35.4 -+ 4% vs. 35.6 -+ 3%; 
heart failure developed in only one patient), systemic hyperten- 
sion occurred in eight patients and conduction disturbances in 
four. Symptoms lessened in 11 patients, were variable or un- 
changed in 64 and worsened in 24. 
Conclusions. Syndrome X, as defined in this study, occurs 
predominantly in postmenopausal women. Patients usually have 
chest pain typical for angina, but conventional ntianginal treat- 
ment is not often successful. Myocardial perfusion abnormalities 
occur in a small proportion of patients. Long-term survival is not 
adversely affected, and deterioration of cardiac function rarely 
occurs, 
(J Am Coil Cardiol 1995;25:807-14) 
The proportion of patients with anginal pain who are found to 
have normal coronary arteriographic f ndings is between 10% 
and 20%, depending on the characteristics of the patient group 
studied (1). The term "syndrome X," first used by Kemp (2) in 
1973, is now frequently used as a diagnostic label for patients 
who have exertional angina, a positive response to exercise 
testing and angiographically normal coronary arteries (3). 
The diagnosis of syndrome X requires exclusion of corona~ 
and other cardiac and extracardiac causes of anginalike chest 
pain (3,4), and it is usually made after costly investigation in 
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search of obstructive coronary artery disease. The documenta- 
tion of normal coronary arteriograms, although welcomed by 
patient and physician, is not enough to solve the dilemma. The 
burden imposed on hospital resources by patients with angina 
and normal coronary arteries is considerable, asthese patients 
continue to use hospital facilities, including emergency and 
coronary care beds, because of recurring, long-lasting chest 
pain. At present, despite many studies carried out over the past 
2 decades, speculation prevails regarding the cause of their 
syndrome. The lack of both a consensus on criteria for the 
diagnosis of syndrome X and clinical gold standards to define 
myocardial ischemia is probably responsible for much of the 
existing controversy regarding the cause of chest pain in this 
syndrome (4,5). 
To date, reports on the syndrome of angina and normal 
coronary arteries have included heterogeneous patient groups 
or focused on selected patient subgroups. Patients with chest 
pain, normal coronary arteriograms and "reduced" coronary 
blood flow reserve (with or without exercise-induced ST seg- 
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ment depression), are considered to have "microvascular 
angina" (6). A sizable proportion of these patients also have 
systemic hypertension (7), and recently it has been suggested 
that patients with microvascular ngina have insulin resistance 
(8,9). Other studies on angina and normal coronary arteries 
have included patients with "near normal" coronary arteries 
(10), coronary artery spasm (11) and left bundle branch block 
(12). The problem of "syndrome X" is further confused by the 
recent use (13) of the same term for a metabolic syndrome 
characterized by hyperinsulinemia, hypertriglyceridemia, hy- 
pertension and coronary artery disease. 
In this study we describe the clinical features and evolution 
of left ventricular function in 99 patients with syndrome X who 
were studied from January 1972 to December 1991 and were 
followed up regularly over a period of 2 to 12.5 years at St. 
George's Hospital, the Royal Brompton National Heart & 
Lung Hospital and Hammersmith Hospital in London, En- 
gland. 
Methods  
Patients. Selection criteria. From a series of 138 consecu- 
tive patients who were referred to our chest pain clinic for 
investigation of anginal pain, we studied 99 (78 women and 21 
men; mean age _+ SD 48.5 _+ 8 years) who met stringent 
criteria for syndrome X: exercise-induced chest pain, positive 
response to exercise testing (->l-ram ST segment depression) 
and normal coronary arteriograms in the absence of coronary 
artery spasm, left ventricular hypertrophy and systemic hyper- 
tension. Of the initial 138 patients, 3 refused participation i  
the study and 36 others were excluded for the following 
reasons: systemic hypertension i 11, left bundle branch block 
in 4, mitral valve prolapse in 4, diabetes mellitus (glucose 
plasma concentration >6 mmol/liter) in 3, negative xercise 
test results in 4, baseline ST segment depression > 1 mm and 
flat or inverted T waves in leads V 2 to V s in 3, coronary 
irregularities at angiography in 5, and symptomatic hiatus 
hernia in 2. None of the 99 patients included in the study had 
Prinzmetal's variant angina pectoris (all had normal findings 
on hyperventilation or ergonovine tests, or both), valvular 
heart disease (including mitral valve prolapse) or overt car- 
diomyopathy. Left ventricular hypertrophy was ruled out by 
echocardiography in all patients. Although no patient was 
hypertensive (blood pressure >140/90 mm Hg) at study entry, 
systemic hypertension developed in eight patients during 
follow-up. Patients with baseline or exercise-induced left bun- 
dle branch block were not included in the study. All patients 
underwent investigations of esophageal function. Esophageal 
disturbances were assessed by manometry and pH measure- 
ments and were ruled out as the cause of chest pain in 84 
patients. In the remaining 15 patients, the first in our series, 
radiologic and endoscopic examination (6 patients) or radio- 
logic examination only (9 patients) showed no abnormalities. 
Myocardial ischemia nd blood flow reserve. Transient myo- 
cardial ischemia was systematically investigated in the 99 
patients as part of their clinical characterization. Ninety-two 
Table 1. Clinical, Electrocardiographic andAngiographic 
Characteristics of 99 Patients With Syndrome X 
Female/male ratio 
Age (yr) 
Coronary artery disease risk factors 
Family history 
Cigarette smoking 
Hypercholesterolemia (>5.4 mmol/liter) 
Gynecologic status 
Hysterectomy 
Age at hysterectomy ( r) 
Natural menopause 
Baseline lectrocardiogram 
Normal 
Flat T waves 
ST segment depression (->0.05 mV) 
Reversible myocardial perfusion defects 
78/21 
48.5 _+ 8 
46 
29 
29 
35 
41+6 
13 
81 
11 
7 
22 
All data are expressed as number of patients or mean value + SD. 
patients underwent dipyridamole or exercise stress myocardial 
perfusion studies (thallium-201, sestamibi technetium-99 or 
rubidium-82 positron emission tomography), which showed 
reversible defects in 22 patients (24%) (Table 1), and 7 
underwent exercise radionuclide ventriculography, which 
showed normal ventricular function in all. Thus, 22 (22%) of 
the 99 patients included in the study had findings compatible 
with stress-related transient myocardial ischemia, as assessed 
by radionuclide techniques. Coronary blood flow reserve, as 
assessed by dipyridamole positron emission tomography (15- 
oxygen water), was reduced in 16 (59%) of 27 patients (below 
the value of 2.5, as reported by Geltman et al. (14) using a 
similar technique), and in 13 (52%) of 25 patients, using 
Doppler flow velocity probes. 
Clinical and electrocardiographic (ECG) characteristics in 
all patients entered in the study are summarized in Table 1. 
Clinical characterization. All patients underwent system- 
atic characterization f their chest pain and coronary artery 
disease risk factors, exercise response, continuous ambulatory 
ECG monitoring and left ventricular function at rest. During 
follow-up, which ranged from 2 to 12.5 years (mean 7 _+ 4 
years), patients were seen at regular intervals (at least two 
annual visits). 
Chest pain. A standardized angina questionnaire was com- 
pleted by every patient. Temporal onset, location and radiation 
of chest pain, number of anginal episodes/week, average 
duration of episodes, triggers of chest pain, association of chest 
pain with exertion, presence of chest pain at rest, associated 
symptoms and the response to sublingual nitrates were inves- 
tigated (Table 2). 
Exercise testing. All patients underwent exercise testing 
using the modified Bruce protocol. Exercise tests were per- 
formed while patients were taking no antianginal medications. 
Nitrates and calcium antagonists were withdrawn ->2 days and 
beta-adrenergic blocking agents ->6 days before the study. 
Exercise test end points were progressive angina, ST segment 
depression ->3 ram, systolic blood pressure ->250 mm Hg and 
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Table 2. Characteristics of Chest Pain in 99 Patients With 
Syndrome X 
Chest Pain Episodes No. 
Onset 
Gradual 75 
Rapid 2'4 
Average duration 
<5 rain 21 
5-10 rain 25 
>10-15 min 211 
> 15 rain 33 
Localization 
Retrosternal 84 
Epigastric 4 
Left shoulder 1 I 
Radiation 
Left arm 35 
Jaw or neck 7 
Back 6 
Arms and neck/back 19 
None 32 
Average no./week 
1-3 32 
3-7 36 
>7 31 
Relation to 
Exertion 99 
+ emotion 9 
+ rest 41 
Predominantly rest pain 14 
fatigue. Twelve-lead ECGs were recorded and blood pressure 
was taken at rest, at l-rain intervals during exercise and for 
->6 rain after exercise. The level of ST segment depression, 
60 ms after the J point, was calculated by a computer-assisted 
system (CASE Marquette 12, Marquette Electronics) in all 12 
leads. The ECG lead showing the greatest ST segment depres- 
sion was selected for analysis. Baseline heart rate and heart 
rate-systolic blood pressure product were measured. Peak ST 
segment depression, exercise time, heart rate and rate-pressure 
product at 1 mm of ST segment depression and at peak 
exercise were measured. The onset of angina during exercise 
was noted. A positive ECG response was defined as horizontal 
or downsloping ST segment depression >1 mm at 60 to 80 ms 
after the J point occurring in at least 16 consecutive beats. A 
small proportion of patients had minor baseline ECG changes, 
as described earlier, but these did not preclude the interpre- 
tation of ST segment changes during exercise. 
Ambulatory ECG monitoring. Ambulatory ECG monitoring 
was performed with the use of Oxford Medilog frequency- 
modulated recorders (Oxford Medical Systems) in the first 19 
patients of the series and Marquette 8500 2-channel amplitude- 
modulated tape recorders in the remaining patients. Record- 
ings were analyzed with an Oxford Medical System Medilog 2 
Analyser and with a Marquette Laser Holter System 8500, 
respectively. In each subject, two leads corresponding to a 
modified inferior lead (or lead V 3 in five patients) and lead V s 
Table 3. Events During Follow-Up in 99 Patients With Syndrome X 
Events No. 
Cardiac death 0 
Myocardial infarction 0 
Chest pain 
Markedly decreased l 1 
Variable 29 
Unchanged 35 
Worse 24 
Hospital admissions 29 
For suspected myocardial infarction 5 
For suspected unstable angina 24 
Systemic hypertension 8 
Conduction abnormalities 4 
Left bundle branch block 2 
Complete heart block l 
Intraventricular conduction disturbances 1 
Impaired left ventricular function 1 
were selected. The lead showing the greatest ST segment 
depression during exercise was always used for assessment. 
The heart rate was measured on an analog recording of the 
heart rate versus time obtained from the playback system 
(trend recording). The number and duration of ischemic 
episodes (defined as horizontal or downsloping ST segment 
depression -> 1 mm from baseline, occurring 0.060 s after the J 
point and lasting at least 60 s) were assessed. The relation of 
ST depression to heart rate changes and the presence or 
absence of angina was investigated. 
Echocardiography. A two-dimensional echocardiographic 
study was performed in all 99 patients at study entry and in 93 
patients at the last follow-up visit (the echocardiographic study 
was not repeated at follow-up in 6 patients who were poor 
echocardiographic subjects). Cardiac images were recorded on 
a 0.75-in. (1.9-cm) video tape recorder for subsequent review. 
Left ventricular end-diastolic and end-systolic dimensions and 
wall thickness (ram) were obtained from a parasternal long- 
axis projection, and the percent fractional shortening contrac- 
tion of the left ventricle (%) was subsequently calculated. All 
measurements were performed by using the echocardiographic 
equipment software. In every patient we assessed both global 
and regional eft ventricular function. Assessment was per- 
formed without knowledge of patient identity or clinical fea- 
tures. 
Follow-up (Table 3). The mean follow-up time was 7 -+ 4 
years (range 2 to 12.5). Patients were followed up regularly at 
6-month intervals during outpatient visits to ascertain health 
status. At each visit, physical examination, blood pressure 
reading and rest baseline ECG were repeated. Exercise testing 
was carried out annually, and echocardiographic assessment of
left ventricular function was performed at least twice during 
follow-up. Chest pain, drug compliance, quality of life and 
performance atwork were assessed by means of standardized 
questionnaires. Hospital admission for suspected cardiac on- 
ditions was noted and hospital reports were obtained where 
appropriate. Patient compliance was excellent. 
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Statistical analysis. Data are expressed as mean value + 1 
SD. Two-tailed Student  test and chi-square tests were used to 
calculate differences in continuous and discrete variables 
among groups, respectively. A p value < 0.05 was considered 
significant. 
Resu l ts  
Clinical features. Table 1 shows the baseline clinical and 
ECG characteristics and risk factors for coronary artery dis- 
ease of the 99 patients. Eleven patients (11%) had flat T waves 
and seven (7%) had minor ST segment depression (->0.05 mV) 
in the baseline ECG. No patient, by selection, had left bundle 
branch block. 
There was a female predominance (79% vs. 21%), and 45% 
of the women (35 of 78) had undergone hysterectomy at an 
average of 8 years before the onset of chest pain. Forty-eight 
women (61.5%) were postmenopausal (13 as a consequence of
natural menopause and 35 after hysterectomy). No patient was 
receiving hormone replacement therapy at the onset of chest 
pain. Fourteen patients who had "vascular instability" symp- 
tomatic of estrogen deficiency were receiving hormone re- 
placement herapy. None of the other postmenopausal pa- 
tients were systematically treated with estrogens during the 
study. 
Chest pain. The characteristics of chest pain in all 99 
patients are presented in Table 2. The symptomatic period 
spanned 2 to 17 years. The chest pain usually had a gradual 
onset, was mainly retrosternal and radiated to the left arm. 
Episodes of chest pain were frequently prolonged (>10 min in 
53% of patients and >15 rain in 33%) and occasionally asted 
>30 min (in 48 patients). In all patients the chest pain was 
related to effort, but 41% of the patients also had chest pain at 
rest. Rest pain was the predominant symptom in 14 patients. 
Episodes of chest pain occurred frequently: Thirty-one pa- 
tients (31%) reported >7 episodes/week and 30 (30%) had >1 
episode/day. 
Exercise testing (Table 4). All exercise test results were 
positive (with angina in 79% of patients). Two groups of 
patients were identified on the basis of the systolic blood 
pressure response to exercise testing: Group 1 (67 patients 
[67%] who showed an increase -<20 mm Hg during the first 
stage of the exercise protocol), and Group 2 (32 patients [32%] 
who had an increase >20 mm Hg). Blood pressure at rest was 
similar in the two patient groups, but systolic blood pressure at 
1 mm of ST segment depression and at peak exercise was 
significantly higher in patients in Group 2. In the latter 
patients, exercise time was significantly shorter, and the mag- 
nitude of the ST segment depression significantly greater, than 
that of patients in Group 1. 
Ambulatory ECG monitoring. Transient ST segment de- 
pression ->1 mm (mean 1.7 _+ 0.3 mm) was observed in 64 
patients. A total of 211 episodes, with a mean duration of 
16.8 _+ 21 min, were recorded; 49% of these were associated 
with chest pain. The onset of ST segment depression was 
preceded by an increased heart rate (>100 beats/rain) in 78% 
Table 4. Exercise Test Variables in 99 Patients With Syndrome X
Patients With Patients With 
SBP Increase SBP Increase 
All Patients <20 mm Hg >20 mm Hg 
(n = 99) (n = 67) (n = 32) 
Rest (before xercise) 
Heart rate (beats/rain) 84 ± 15 84 ± 16 83 ± 14 
Blood pressure (mm Hg) 126 _+ 7 125 -+ 18 127 + 16 
l-ram ST depression 
Heart rate (beats/rain) 132 _+ 23 133 _+ 24 130 + 22 
Blood pressure (mm Hg) 152 + 25 142 + 19 176 ± 21" 
Time (s) 324 ± 246 379 ± 219 296 + 170t 
Peak exercise 
Heart rate (beats/rain) 151 _+ 21 152 _+ 22 147 + 19 
Blood pressure (mm Hg) 163 _+ 26 154 _+ 22 184 + 24* 
Time (s) 502 ± 197 569 - 224 460 ± 159' 
*p < 0.01. tp < 0.05 versus patients with systolic blood pressure (SBP) 
increase <20 mm Hg. All data re expressed asmean value ± SD. 
of episodes. One hundred twenty-four episodes of chest pain 
that were not associated with ST segment depression were 
recorded in 80 patients. Ventricular arrhythmias were ob- 
served in five patients (bigeminy in two patients, multifocal 
ventricular premature beats in one patient and short runs of 
ventricular tachycardia in two patients). These arrhythmias 
were not associated with episodes of ST segment depression. 
Left ventricular function (Table 5). No patient had struc- 
tural or functional valve disease, and all had normal global and 
regional eft ventricular wall motion at baseline examination. 
No patient, by selection, had echocardiographic evidence of 
left ventricular hypertrophy. Left ventricular mass index was 
86 _+ 3 g/m 2 in the 78 women and 101 _+ 8 g/m 2 in the 21 men. 
Mean left ventricular ejection fraction was 68 + 8% (range 
53% to 85%). A left ventricular ejection fraction >75% was 
observed in nine patients (9%). 
Patient characterization costs. The cost of initial diagnos- 
tic investigations using conventional techniques including cor- 
onary arteriography ranged from £2,200 ($3,520) to £3,830 
($6,128), depending on whether clinical presentation was with 
chronic exertional chest pain or with rest angina that suggested 
the possibility of unstable angina or non-Q wave myocardial 
infarction. The burden on the health service was not negligible 
during follow-up, as 29 patients required a repeat hospital 
admission for suspected myocardial infarction or unstable 
angina and 6 patients underwent repeat coronary arteriogra- 
Table 5. Left Ventricular Function As Assessed by Echocardiography 
in 99 Patients With Syndrome X at Study Entry and at Follow-Up* 
Baseline Follow-Up 
(n = 99) (n = 93) 
LVEDD (ram) 49.6 _+ 2.7 49.4 -+ 3.0 
LVESD (ram) 32.0 = 2.0 31.7 -+ 2.2 
Shortening fraction (%) 35.4 -+ 4.0 35.6 -+ 3.0 
*Mean follow-up interval _+ SD = 7 + 4 years. All data re expressed as
mean value ± SD. LVEDD (LVESD) - left ventrieular end-diastolic (end- 
systolic) dimension. 
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phy. Regular outpatient visits were also necessary because of 
persistent symptoms in the majority of patients. 
Follow-up. Chest pain and major coronary events. The ma- 
jority of our patients continued to have chest pain, but none 
died or had an acute myocardial infarction during follow-up. 
Despite the overall good prognosis, 29 patients were admitted 
to the hospital, including the coronary care unit, at some stage 
of follow-up. Twenty-four patients were admitted with the 
diagnosis of unstable angina (usually rest angina and ST 
segment or T wave changes), and five were admitted for 
suspected non-Q wave acute myocardial infarction. Conduc- 
tion disturbances developed in four patients: two had left 
bundle branch block, one had intraventricular conduction 
disturbances, and one had complete heart block that required 
implantation of a permanent pacemaker. 
Exercise response. The mean exercise duration and peak ST 
segment depression were similar at baseline and last follow-up 
visit (526 s vs. 512 s, and 1.9 mm vs. 1.8 ram, respectively). 
Systemic hypertension developed in 8 patients; six (75%) of 
these were in the group that showed a greater blood pressure 
increase during stage I of the exercise protocol. 
Left ventricular function. Average echocardiographic rest 
left ventricular volumes and left ventricular shortening frac- 
tion, as well as global and regional eft ventricular function, 
remained unchanged uring follow-up (Table 5). In only 2 
(2%) of the 93 patients who underwent repeat echocardio- 
graphic measurements was global ejection fraction significantly 
reduced from the baseline value (from 53% to 21% and from 
61% to 54%, respectively). Symptomatic left ventricular failure 
and intraventricular conduction disturbances also developed in 
the first of these two patients, and left bundle branch block 
developed in the other during follow-up. Baseline and follow-up 
echocardiographic measurements are presented in Table 5. 
Treatment. Antianginal medication. Assessment of antian- 
ginal therapy was beyond the scope of this study and drug 
efficacy was not systematically investigated. However, clinical 
characterization of medical therapies used during follow-up 
was carried out. Therapy with a single agent appeared to be of 
symptomatic benefit in 29 patients (29%). Calcium antago- 
nists, usually verapamil (240 mg/day) or diltiazem (180 to 
360 mg/day), lessened both exertional and rest angina in 21 
(31%) of 68 patients. Beta-adrenergic blocking agents (usually 
atenolol 50 to 100 mg/day) were effective for relief of symp- 
toms in 8 (19%) of 42 patients in whom the agent was tried. In 
13 (45%) of the 29 patients, lessening of symptoms was long 
lasting (->8 months). Oral nitrates (isosorbide dinitrate or 
mononitrate) were useful in combination with calcium antag- 
onists in 28 (42%) of 66 patients and with beta-blockers in 10 
(30%) of 33 patients. Sublingual isosorbide dinitrate or nitro- 
glycerin promptly relieved episodes of chest pain in 42 (42%) 
patients of the 99 patients, but these agents were less effective 
in 26 patients (26%) or not effective in 31 patients (31%). In 67 
(67%) of the 99 patients, diverse combinations of antianginal 
agents were required for treatment of chest pain. In these 
patients, ymptomatic improvement i  response to the diverse 
antianginal drug combinations and dosages was often short- 
lived (mean 3 _+ 3 months). 
Hormone replacement therapy for menopausal women with 
syndrome X. Only 14 women received estrogen replacement 
therapy for control of menopausal symptoms. We did not 
attempt o formally characterize the response to hormone 
replacement therapy in patients with syndrome X until 1991. 
Preliminary results of these studies (15,16) have recently been 
reported. 
Life-style. Eleven patients were asymptomatic or felt signif- 
icantly improved at last follow-up visit, whereas 35 patients 
reported no change in symptoms from baseline. In 29 patients, 
symptomatic periods (frequently during the cold winter 
months) of variable duration alternated with periods of few or 
no symptoms. Twenty-four patients were significantly limited 
in daily activities, and eight of these abandoned work because 
of refractory chest pain. "Spontaneous" remission of chest 
pain (->6 months) was observed in six patients (6%) who 
received no antianginal treatment. 
Discussion 
The patients described in this study fulfilled stringent 
criteria for syndrome X and represent the largest clinically 
homogeneous series of patients with this syndrome reported 
on to date. We required the presence of a positive response to 
exercise testing for the diagnosis of syndrome X in an attempt 
to reduce clinical heterogeneity and to try to identify patients 
whose chest pain was likely to have a cardiac origin. However, 
even if defined by "ischemic" ECG changes during exercise, 
syndrome X may still encompass diverse pathophysiologic 
entities. The absence of ST segment depression during exercise 
does not rule out "microvascular angina," as described by 
Cannon et al. (7), but even in that group's series (17), an 
ischemic response of the left ventricular ejection fraction to 
exercise was more common in patients with transient ST 
segment depression than in patients without ST segment shifts. 
Cannon et al. (17) also observed that coronary flow reserve was 
significantly lower in patients with microvascular ngina who 
had an ischemic ST segment response to dipyridamole than in 
those who did not have ST segment changes. These observa- 
tions are in agreement with findings by Camici et al. (18), who 
observed that 12 of 14 patients with reduced coronary flow 
reserve, compared with 16 of 29 with normal flow reserve, had 
ischemic ST segment depression during exercise testing. 
Clinical features. Our results confirm previous observa- 
tions (19,20) of a female prevalence among patients with 
syndrome X and suggest that estrogen deficiency may play a 
pathogenetic role in women with this syndrome, as discussed 
elsewhere (21). Indeed, of the 78 women in our study, 48 were 
postmenopausal. The finding of a female prevalence in syn- 
drome X is not universal; Pasternak (22) and Kemp (23) and 
their coworkers did not find such a high prevalence of women 
in their series. It may be that patients included in their large 
studies did not fulfill the strict criteria for syndrome X that we 
applied to the patients in our prospective study. Their patients 
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had normal or "near-normal" coronary arteries, and some had 
systemic hypertension or negative xercise test results. In our 
study, although we included a large number of consecutive 
patients, some bias could have been introduced by the propor- 
tion of patients who were referred to our chest pain clinic by 
cardiologists aware of our interest in syndrome X. However, 
these factors do not explain why there appears to be an 
increased prevalence of the syndrome in women. 
A sizable proportion of our patients had a family history of 
coronary disease and elevated plasma cholesterol levels. This 
finding could be explained by the fact that, in our system, 
physicians frequently perform cardiac catheterization in "high 
risk" patients with angina, particularly in younger patients who 
also have coronary artery disease risk factors. 
Chest pain and myocardial ischemia. In our patients, chest 
pain was mainly exertional and practically indistinguishable in
character, location and radiation from that in patients with 
obstructive coronary artery disease. However, as observed by 
other investigators (7), angina in the majority of patients had 
atypical features, including the presence of rest pain, a pro- 
longed duration of attacks and a poor response to sublingual 
nitrates. 
In the present study, both effort-induced chest pain and rest 
angina were associated with ST segment depression suggestive 
of myocardial ischemia. Although ST segment depression is 
not an entirely specific sign of myocardial ischemia, this finding 
cannot be summarily dismissed as an index of ischemia. 
Transient myocardial ischemia may indeed be the cause of 
chest pain in syndrome X. However, the atypical features of 
the pain in some patients, the lack of myocardial dysfunction i
our study and that of others (24) and the essentially good 
prognosis (l,10,20,22) have cast doubts as to the ischemic 
nature of syndrome X (4,5,25). In the present study, we 
obtained objective documentation of transient myocardial 
perfusion abnormalities in a substantial proportion of patients. 
However, whether such abnormalities in these patients truly 
indicate myocardial ischemia requires confirmation. The pres- 
ence of ischemia in syndrome X is controversial, but net lactate 
production (26-29), a decrease in coronary sinus oxygen 
saturation (30), transient abnormalities of myocardial perfu- 
sion (11,31) and left ventricular function (32) have been found 
in patients with syndrome X or microvascular ngina, or both. 
Data by Opherk et al. (33) suggest hat syndrome X in some 
patients may represent a "cardiomyopathic" process that re- 
suits from repeated ischemic myocardial injury associated with 
coronary microvascular dysfunction. Although myocardial isch- 
emia may be the underlying mechanism in at least some 
patients with syndrome X, the tools commonly used to detect 
myocardial ischemia in clinical practice may not be sensitive 
enough to detect the rather less severe or "patchy" (34) 
ischemia of syndrome X. 
It is also conceivable that mechanisms other than myocar- 
dial ischemia may cause syndrome X, as suggested by the 
paucity of objective signs of ischemia despite severe and 
prolonged chest pain in many patients with syndrome X. It has 
been speculated (35) that chest pain in syndrome X is the 
result of an abnormal pain perception. Turiel et al. (35), 
Shapiro et al. (36) and Cannon et al. (37) observed an 
increased sensitivity to pain in response to diverse stimuli in 
patients with angina and normal coronary arteriograms. Al- 
though pain perception may be abnormally heightened in 
patients with syndrome X, this is unlikely to be the only 
explanation for the syndrome. Local release of adenosine (34), 
a mediator of cardiac pain, and an abnormal function of 
adenosine receptors (38) have been suggested as an alternative 
explanation for chest pain in the absence of myocardial 
ischemia in syndrome X. Further supporting a nonischemic 
origin for syndrome X, Camici et al. (39) recently identified a 
small group of patients with normal coronary arteriograms and 
positive exercise test results who had myocardial metabolic 
abnormalities during atrial pacing. These abnormalities were 
not consistent with myocardial ischemia despite the occurrence 
of typical chest pain and ST segment depression. 
Hemodynamie and ECG response during exercise testing. 
On average, patients with syndrome X and coronary artery 
disease have a similar time course of ST segment depression 
during exercise testing (40). Recently, however, it has been 
observed (41) that some patients with syndrome X have an 
exaggerated response of the rate-pressure product during 
exercise, which may be the result of an increased sympathetic 
drive. This hypothesis i further suggested by the findings of 
Galassi et al. (42), who observed that patients with syndrome X
had a higher heart rate at rest throughout the 24 h (as assessed 
by ambulatory ECG monitoring) than did normal persons or 
patients with coronary artery disease. In our study, systolic 
blood pressure increased by >20 mm Hg during the first stage 
of the exercise protocol in one third of patients. Increased 
sympathetic activity may be one explanation for this observa- 
tion. These patients ubsequently showed ahigher incidence of 
systemic hypertension during follow-up. An association be- 
tween borderline or established hypertension and syndrome X
may exist. One third of patients reported by Cannon et al. (7) 
were hypertensive or reported a history of hypertension, 
although they did not have left ventricular hypertrophy. It has 
been shown (11,43,44) that systemic hypertension, even with- 
out left ventricular hypertrophy, can be associated with re- 
duced coronary vasodilator reserve. 
That an autonomic imbalance that results in a predomi- 
nance of sympathetic activity is present in syndrome X has 
been confirmed by recent studies from our group (45) using 
heart rate variability analysis. This observation is in agreement 
with recent findings by Montorsi et al. (46) in patients with 
angina, normal coronary arteriograms and abnormal baseline 
ECGs. Moreover, the observation by Tousoulis et al. (47) of 
left ventricular hypercontractility n patients with syndrome X
also favors the hypothesis that increased sympathetic tone may 
play a pathogenic role in syndrome X. However, the alpha- 
adrenergic blocker prazosin does not appear to be effective for 
treatment of this syndrome (48). 
Left ventricular function at follow-up. As also suggested by 
other studies (1,10,49,50), syndrome X is associated with a 
benign prognosis, particularly in relation to cardiac mortality, 
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the development of serious coronary events and heart failure. 
Indeed, none of our patients died or had a myocardial infarc- 
tion during long-term follow-up, and dilated cardiomyopathy 
and heart failure developed in only one patient. These results 
differ from findings by Opherk et al. (33), who observed a
decline in left ventricular ejection fraction during follow-up in 
13 of 27 patients with syndrome X. Different inclusion criteria 
and patient selection may explain these differences. The pa- 
tients described by Opherk et al. (33) were predominantly male 
and a large proportion had left bundle branch block at baseline 
or during exercise at study entry. In patients with chest pain 
and normal coronary arteriograms, progressive deterioration 
of left ventricular function thus appear to occur more fre- 
quently in those who present with left bundle branch block or 
develop intermittent left bundle branch block during exercise 
or pacing (33,51). We did not include patients with left bundle 
branch block, and it developed in only two patients during 
follow-up. These findings may explain why heart failure was 
such a rare event in our study. However, it is important that left 
bundle branch block developed in one of the two patients who 
had a reduced ejection fraction at follow-up and that an 
intraventricular conduction disturbance developed in the 
other. 
Although not systematically investigated with objective 
means, single-drug antianginal treatment was effective in con- 
trolling symptoms in a relatively small proportion of patients in 
the study. In the majority of patients, frequent dosage adjust- 
ments and different combinations of antianginal agents were 
required. Sublingual nitroglycerin was ineffective in relieving 
chest pain in >50% of patients. These findings are in agree- 
ment with observations by Kemp et al. (23). The majority of 
our patients remained symptomatic throughout the follow-up 
period, and some were disabled because of persistent chest 
pain. A long-lasting decrease in anginal symptoms was noticed 
in only a small proportion of patients. Thus, although patients 
with syndrome X as defined in this study have a good prognosis 
in terms of survival, preservation of left ventricular function 
and major coronary events, most are seriously limited by chest 
pain. 
Patient characterization costs. The financial burden im- 
posed by this condition to the health service, insurance com- 
panies or the patient is not negligible. Costs are particularly 
high in patients who have prolonged chest pain at rest that 
does not respond promptly to sublingual nitrates. Because 
their symptoms can mimic unstable angina or non-Q wave 
myocardial infarction, these patients often require admission 
to the coronary care unit and costly investigations. In our 
study, for example, costs for diagnostic investigation of patients 
who presented with prolonged angina at rest usually exceeded 
£3,500 ($5,600). Costs for the initial assessment of patients 
with chronic exertional angina exceeded £2,200 ($3,520). Pa- 
tient evaluation costs in the United States are likely to average 
$7,000 (Lonny Reisman, MD, personal communication, March 
1994). 
Conclusions. Syndrome X occurs more commonly in post- 
menopausal women than in men or other women. Chest pain 
is often typical of angina pectoris, but may be prolonged and 
poorly responsive to conventional ntianginal therapy. Myo- 
cardial ischemia, as detected by conventional means other than 
the ECG, appears to account for the chest pain in a relatively 
small proportion of patients. In some patients, borderline 
hypertension may be a contributory mechanism, and the blood 
pressure response during exercise may help to identify these 
patients. Although long-term survival is not adversely affected 
in patients with syndrome X, life style is often impaired by 
prolonged and recurrent chest pain. Deterioration of left 
ventricular function rarely occurs in patients with syndrome X
as defined in this study. Investigation and treatment of patients 
with this syndrome are usually costly, and therapy with con- 
ventional antianginal agents is rarely successful. 
We are grateful to Linda A. Bergthold, PhD and Lonny Reisman, MD, FACC of 
William M. Mercer Inc., New York, New York for information on costs of 
evaluating syndrome X in the United States. 
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